At what enterprise value was VOYAGE CARE acquired in 2022?

During the acquisition of VOYAGE CARE by WREN HOUSE in 2022, the transaction's Enterprise Value is estimated to be in the range of 500M - 1.5b EUR.

What was the EV/EBITDA of VOYAGE CARE when it was acquired by WREN HOUSE?

The estimated EV/EBITDA multiple for VOYAGE CARE is in the range of 10x - 18x.

When was VOYAGE CARE acquired by WREN HOUSE?

VOYAGE CARE was acquired by WREN HOUSE in 2022.

What was the revenue of VOYAGE CARE at the time of the deal?

The revenue of VOYAGE CARE at the time of the deal is estimated to be in the range of 250M - 500M EUR.

What was the EBITDA of VOYAGE CARE during the acquisition?

VOYAGE CARE's EBITDA is estimated to be in the range of 25M - 50M EUR.

How is the data for the VOYAGE CARE acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the VOYAGE CARE deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.voyagecare.com/wp-content/uploads/2024/12/Press-Release-14-Jan-2022-Wren-House-Aquisition.pdf

← DATABASE

Home Database Healthcare & PharmaVOYAGE CARE

01/2022

VOYAGE CARE acquired by WREN HOUSE

UNITED KINGDOM Health Providers / Healthcare Facilities / Nursing Homes EV 500M - 1.5b EUR

Context

Partners Group and Duke Street agreed to sell 100% of Voyage Care to Wren House Infrastructure Management, following approximately seven years of joint ownership since the 2014 acquisition alongside management. Key value creation initiatives delivered during the holding period include strategic management hires, continued investment in care quality, further development of specialist care disciplines, and capacity expansion through organic development and selective bolt-on acquisitions.

VOYAGE CARE, which reported an EBITDA margin of in 2022, is valued in this transaction at an EV/EBITDA multiple of , representing a to the average currently observed in the Healthcare & Pharma sector (15.3x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Voyage Care is a leading UK provider of specialist care and support services, founded in 1988 and headquartered in Lichfield. The company provides highly specialised care to people with learning and physical difficulties, brain injuries, autism, and other complex needs across the United Kingdom. A large majority of those supported by Voyage Care require high levels of care and support throughout their lives, making the company a critical long-term provider of essential social care services.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2022

2021

Similar deals in Health Providers

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
04/2022	GROUPE BRUXELLES LAMBERT	AFFIDEA	NETHERLANDS	Radiology
02/2022	MEINE RADIOLOGIE	ALERIS - RADIOLOGY	SWEDEN	Radiology
12/2021	RAMSAY HEALTH CARE	ELYSIUM HEALTHCARE	UNITED KINGDOM	Clinics / Hospitals
12/2021	VIVALTO PARTNERS / IK PARTNERS / MACSF / ARKEA CAPITAL / BNP PARIBAS DEVELOPPEMENT	VIVALTO SANTÉ	FRANCE	Clinics / Hospitals
11/2021	CERBA HEALTHCARE	LABEXA	FRANCE	Labs (Biology)
10/2021	IVC EVIDENSIA	VETONE	FRANCE	Vet Clinics
10/2021	THE CRANEMERE GROUP	OUTPATIENT IMAGING AFFILIATES	UNITED STATES	Radiology
10/2021	ARES / BPIFRANCE	POINT VISION	FRANCE	Ophthalmology
09/2021	LIVINGBRIDGE	EVERLIGHT RADIOLOGY	UNITED KINGDOM	Radiology
08/2021	COLOSSEUM DENTAL GROUP	CURAEOS	NETHERLANDS	Dental Centers

REFERENCES

Valuation range: EV 500M - 1.5b EUR

Revenue range: 250M - 500M EUR

EBITDA range: 25M - 50M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of VOYAGE CARE by WREN HOUSE are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Acquirer: wren house